ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
BioTech/Drugs - , ,
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Employees
Kristin Zemanek
Associate Vice President, Organizational Learning and Development
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Senior Management
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Details
ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. On November 24, 2008, ImClone Systems became a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY).
Website:
imclone.com
Employees:
1000 - 4999
HQ:
N/A
Location:
, ,
Revenue:
10 - 20 Million
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Technologies
Domain Name Services
CSC Corporate Domains
Other
Microsoft Office 365